🟢 XBI is trading 3.1% up today on biotech earnings strength and broader risk-on rally

XBI is trading 3.1% up today at $151.83, benefiting from a strong biotech sector rally and broader risk-on sentiment across U.S. equities.

• Biotech names are climbing on better-than-expected Q2 earnings, upbeat IPO/M&A activity, and strong revenue growth at key holdings like ImmunityBio.
• The S&P 500 and Nasdaq are also rising sharply as favorable macro data and easing energy prices support broader risk assets.